Glucocorticoid-free induction regimen in severe ANCA-associated vasculitis using a combination of rituximab and eculizumab

Rheumatology (Oxford). 2019 Dec 1;58(12):2335-2337. doi: 10.1093/rheumatology/kez190.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / drug therapy*
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Complement Inactivating Agents / administration & dosage
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Glucocorticoids
  • Humans
  • Immunologic Factors / administration & dosage
  • Remission Induction / methods*
  • Rituximab / administration & dosage*

Substances

  • Antibodies, Monoclonal, Humanized
  • Complement Inactivating Agents
  • Glucocorticoids
  • Immunologic Factors
  • Rituximab
  • eculizumab